Subsequent Events (Details) - USD ($)			1 Months Ended		12 Months Ended
	Mar. 09, 2021	Feb. 11, 2021	Mar. 31, 2021	Nov. 23, 2020	Dec. 31, 2020	Dec. 31, 2019	Mar. 12, 2021
Subsequent Event [Line Items]
Proceeds from issuance of common stock, net of issuance costs					$ 15,821,922	$ 4,782,509
Subsequent Event [Member] | Office and Laboratory Space [Member]
Subsequent Event [Line Items]
Operating lease option to extend			The extension is for four years beginning in September of 2021 with an optional four year extension through September 2029.
Minimum operating lease payments			$ 810,000
Healthcare-focused Institutional Investor [Member] | February 2021 Offering [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Stock issued during period, shares, new issues		2,784,184
Gross proceeds from sale of common stock		$ 25,000,000
Proceeds from issuance of common stock, net of issuance costs		$ 23,400,000
Healthcare-focused Institutional Investor [Member] | February 2021 Offering [Member] | Subsequent Event [Member] | Pre Funded Warrant [Member]
Subsequent Event [Line Items]
Stock issued during period, shares, new issues		5,549,149
Sale of stock, description of transaction		Each pre-funded warrant exercisable for one share of common stock.
Investor [Member] | February 2021 Offering [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Offering of common stock and warrants		4,166,666
Shares issued, price per share		$ 3.00
Class of warrant or right, exercise price of warrants or rights		$ 3.55
Warrants exercisable period		6 months
Warrants expiry period		5 years 6 months
Investor [Member] | February 2021 Offering [Member] | Subsequent Event [Member] | Pre Funded Warrant [Member]
Subsequent Event [Line Items]
Shares issued, price per share		$ 2.99
Class of warrant or right, exercise price of warrants or rights		$ 0.01
Holder [Member] | Purchase Agreement [Member] | Warrant [Member]
Subsequent Event [Line Items]
Offering of common stock and warrants				4,842,615
Class of warrant or right, exercise price of warrants or rights				$ 1.94
Warrants expiry period				5 years 6 months
Holder [Member] | Exercise Agreement [Member] | Subsequent Event [Member] | Warrant [Member]
Subsequent Event [Line Items]
Class of warrant or right, exercise price of warrants or rights	$ 3.56						$ 0.08125
Warrants expiry period	5 years
Number of warrants outstanding	4,842,615
Number of each warrant issue to purchase common stock	0.65
New warrants issue against outstanding warrants	3,147,700
Payment to purchase new warrants	$ 255,751
Description of expenses related to purchase warrants	The Company received aggregate gross proceeds before expenses of approximately $9.65 million from the exercise of all of the remaining 4,842,615 outstanding Existing Warrants held by the Holder